Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of bioactive molecules and drug candidates. Its structure supports the creation of compounds with central nervous system activity, including potential antipsychotic and antidepressant agents. Commonly employed in medicinal chemistry for building blocks in heterocyclic compound design, it facilitates structure-activity relationship (SAR) studies due to the presence of both bromine and morpholine moieties, enabling further functionalization through cross-coupling reactions. Also utilized in the preparation of kinase inhibitors and receptor modulators in research settings.